Ticker: ALB

Albemarle

Materials Materials Chemicals - Specialty

Price 123.74

Reco Sell Potential 31 Risk 72 Updated 2026-09-09

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Company and Business Model

Albemarle Corporation is a global leader in specialty chemicals, primarily focused on lithium, bromine, and catalysts. The company operates in three major segments: Lithium, Bromine Specialties, and Catalysts. Its core products include lithium compounds for electric vehicle batteries, bromine-based flame retardants, and catalysts for refining and petrochemical processes. The main revenue sources are derived from lithium sales, which have seen significant growth due to increasing demand in the electric vehicle market.

Investment Profile

The investment profile of Albemarle is more aligned with growth investors, given its focus on expanding lithium production and the potential for increased demand in the renewable energy sector. The company offers a modest dividend yield, appealing to those seeking some income, but its primary attractiveness lies in growth potential. The stock may suit medium to long-term investors looking for exposure to the materials sector.

Category: Materials Sector: Materials Industry: Chemicals - Specialty Investment style: Growth Horizon: Long-term Company type: Market Leader Experience: Basic

Fundamental metrics (experimental) Updated: 2026-09-10

EPS (TTM) — earnings per share for the last 12 months, $: -3.40
Revenue QoQ — quarter-over-quarter revenue growth: 0.0%
EPS surprise: -32.5%
20d volatility: 2.7%
Dividend yield: 1.2%
last ex-date: 2026-03-13

AI recommendation changes

Date	Before	After	Reason
2026-06-21	Hold	Sell	Weak fundamentals and negative momentum raise significant concerns.
2026-06-13	Sell	Hold	Weak fundamentals and high risk offset recent price momentum.
2026-06-05	Hold	Sell	Weak fundamentals and negative momentum raise significant concerns.
2026-05-08	—	Hold	Strong momentum, but fundamentals show weakness.
2026-05-08	Hold	Buy	Компания демонстрирует сильный рост за последние 120 дней, что указывает на высокий потенциал. Однако отрицательный EPS и высокая волатильность требуют осторожности.
2026-04-03	Buy	Hold	Компания показывает сильный рост за последние 120 дней, но отрицательный EPS и значительное снижение прибыли по сравнению с ожиданиями вызывают опасения. Рекомендуется удерживать акции до прояснения финансовых показателе
2026-03-25	Hold	Buy	Компания Albemarle демонстрирует сильный рост за последние 120 дней, что указывает на положительную динамику. Несмотря на отрицательный EPS, рост выручки и дивидендная доходность делают её привлекательной для инвестиций.
2026-03-07	Buy	Hold	Компания демонстрирует сильный рост за последние 120 дней, однако недавние колебания цен и отрицательный EPS могут указывать на риски. Рекомендуется удерживать акции до более ясной картины финансовых показателей.
2026-02-26	Hold	Buy	Компания показывает значительный рост за последние 60 и 120 дней, что свидетельствует о сильном спросе на продукцию. Несмотря на отрицательный EPS, положительная динамика выручки и высокая волатильность могут привлечь ин
2026-02-14	Buy	Hold	Компания Albemarle демонстрирует сильный рост за последние 120 дней, что указывает на позитивные перспективы. Однако отрицательный EPS и снижение выручки в квартальном выражении могут быть предупреждающим знаком.

Analyst forecasts

Date	Analyst	Action	Target	Price Then
2026-08-10	Scotiabank	Target Lowered	200 → 190	131.11
2026-08-10	Morgan Stanley	Target Lowered	189 → 161	131.11
2026-08-07	Truist Financial	Target Lowered	245 → 225	128.49
2026-08-07	UBS	Target Lowered	205 → 175	128.86
2026-07-17	RBC Capital	Target Lowered	257 → 166	118.83
2026-05-26	RBC Capital	Target Raised	253 → 257	177.4
2026-05-26	Vertical Research	Update	— → 224	171.58
2026-05-14	Scotiabank	Target Raised	200 → 215	191
2026-05-12	Deutsche Bank	Target Raised	210 → 250	206.88
2026-05-11	RBC Capital	Target Raised	245 → 253	216.2
2026-05-11	Argus Research	Target Raised	185 → 230	215
2026-05-08	UBS	Target Raised	230 → 264	198.01
2026-05-08	Truist Financial	Target Raised	245 → 260	198.35
2026-04-24	RBC Capital	Target Raised	216 → 245	185.375
2026-04-14	Morgan Stanley	Target Raised	170 → 189	186.22
2026-04-09	UBS	Target Raised	220 → 230	172.35
2026-03-06	Truist Financial	Update	— → 210	158.91
2026-02-23	Berenberg Bank	Target Raised	135 → 153	168.42
2026-02-18	Evercore ISI	Target Raised	100 → 180	173.46
2026-02-17	RBC Capital	Target Raised	200 → 216	170.25
2026-02-16	Wells Fargo	Target Lowered	174 → 165	166.35
2026-02-13	Morgan Stanley	Target Raised	147 → 170	165.85
2026-02-12	Mizuho Securities	Target Raised	156 → 185	175.43

News Page 1 of 1

Analysts recommend buying dividend stocks as they outperform the S&P 500 in July

08/03/2026, 11:38 AM investing recommendation Analysts: analysts finance ProShares Air Products and Chemicals Vanguard Albemarle Walmart

Dividend stocks have shown resilience amid market volatility, outperforming the S&P 500 in July, which could signal a strategic shift for investors looking for stability and growth potential.

Market Volatility Leads to Oversold Stocks, Including Intercontinental Exchange (ICE) and CME Group (CME)

06/27/2026, 06:32 AM investing review Intercontinental Exchange Albemarle CME Group Akamai Technologies

After a volatile week in the market, several stocks have entered oversold territory, indicating potential for a rebound, particularly in the tech sector and trading platforms like Intercontinental Exchange and CME Group, which are facing competitive pressures.